City Holding Co. Has $1.74 Million Holdings in CME Group Inc. $CME

Key Points

• City Holding Co. has increased its stake in CME Group Inc. by 20.4% in the second quarter, holding a total of 6,306 shares valued at approximately $1.74 million.
• Several institutional investors, including Vanguard Group and Raymond James, have also increased their positions in CME Group, contributing to the company's 87.75% ownership by institutional shareholders.
• CME Group recently reported a quarterly earnings per share (EPS) of $2.96, surpassing analysts' expectations, with revenues increasing by 10.4% year-over-year.

City Holding Co. raised its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 20.4% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 6,306 shares of the financial services provider's stock after buying an additional 1,068 shares during the quarter. City Holding Co.'s holdings in CME Group were worth $1,738,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in the business. Vanguard Group Inc. lifted its stake in CME Group by 1.2% in the 1st quarter. Vanguard Group Inc. now owns 34,643,827 shares of the financial services provider's stock valued at $9,190,661,000 after acquiring an additional 400,737 shares in the last quarter. Raymond James Financial Inc. increased its stake in shares of CME Group by 9.7% during the first quarter. Raymond James Financial Inc. now owns 4,113,991 shares of the financial services provider's stock worth $1,091,401,000 after purchasing an additional 363,130 shares during the period. Massachusetts Financial Services Co. MA increased its position in CME Group by 29.9% during the 1st quarter. Massachusetts Financial Services Co. MA now owns 2,818,590 shares of the financial services provider's stock worth $747,744,000 after buying an additional 648,591 shares during the period. AQR Capital Management LLC increased its holdings in shares of CME Group by 10.3% during the first quarter. AQR Capital Management LLC now owns 2,783,759 shares of the financial services provider's stock worth $735,539,000 after purchasing an additional 260,065 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in CME Group by 11.9% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,727,809 shares of the financial services provider's stock worth $723,660,000 after acquiring an additional 290,147 shares during the period. Institutional investors and hedge funds own 87.75% of the company's stock.

Insider Buying and Selling

In other CME Group news, insider Sunil Cutinho sold 11,896 shares of the firm's stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total value of $3,229,407.12. Following the completion of the sale, the insider directly owned 17,440 shares in the company, valued at $4,734,436.80. This trade represents a 40.55% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Timothy Francis Mccourt sold 379 shares of the business's stock in a transaction dated Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total value of $98,475.57. Following the completion of the transaction, the insider directly owned 9,508 shares of the company's stock, valued at approximately $2,470,463.64. This trade represents a 3.83% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 13,043 shares of company stock valued at $3,527,956. Insiders own 0.30% of the company's stock.

CME Group Trading Up 0.6%

NASDAQ CME opened at $270.28 on Friday. The stock has a 50 day simple moving average of $270.87 and a two-hundred day simple moving average of $270.96. CME Group Inc. has a fifty-two week low of $213.94 and a fifty-two week high of $290.79. The stock has a market cap of $97.40 billion, a P/E ratio of 26.16, a price-to-earnings-growth ratio of 4.89 and a beta of 0.43. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.05. The firm had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.CME Group's quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.56 EPS. On average, analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were issued a $1.25 dividend. The ex-dividend date was Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. CME Group's payout ratio is 48.40%.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on CME shares. Citigroup upgraded CME Group from a "neutral" rating to a "buy" rating and lifted their price target for the company from $275.00 to $300.00 in a research note on Thursday. UBS Group reduced their price objective on shares of CME Group from $305.00 to $285.00 and set a "neutral" rating on the stock in a research note on Monday, September 8th. Barclays set a $298.00 price target on CME Group and gave the stock an "equal weight" rating in a report on Thursday, July 24th. Piper Sandler increased their price target on CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a report on Tuesday, July 15th. Finally, Wall Street Zen lowered shares of CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. Five equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $268.14.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.